Dravet syndrome an unusual cause of atypical febrile seizure: a case report

Authors

  • Prem Patel Department of Paediatrics, Ananta Institute, Medical Sciences and Research Institute, Rajsamand, Rajasthan, India
  • Prasun Bhattacharjee Department of Paediatrics, Ananta Institute, Medical Sciences and Research Institute, Rajsamand, Rajasthan, India
  • Keeranmayee Mishra Department of Obstetrics and Gynaecology, Banas Medical College and Research Centre, Palanpur, Gujarat, India
  • Pranay Trivedi Department of Paediatrics, Ananta Institute, Medical Sciences and Research Institute, Rajsamand, Rajasthan, India
  • Ashwani Parashar Department of Paediatrics, Ananta Institute, Medical Sciences and Research Institute, Rajsamand, Rajasthan, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20242349

Keywords:

Dravet syndrome, Pediatric epilepsy, Refractory epilepsy, Encephalopathy

Abstract

Dravet syndrome is a rare refractory epileptic encephalopathy with an underlying genetic basis. It presents with recurrent febrile seizures in infancy. Though development is normal in infancy, neurodevelopmental delay and neurologic disability begin after the onset of seizure at the age of around 2-4 years. The outcome can be improved by early diagnosis (genetic testing for SCN1A gene) and timely treatment. In this case report we are presenting a 3-year-old female child with recurrent refractory epilepsy associated with fever and was diagnosed with Dravet syndrome.

Metrics

Metrics Loading ...

References

Anwar A, Saleem S, Patel UK, Arumaithurai K, Malik P: Dravet syndrome: An overview. Cureus. 2019;11:5006-10.

Wu YW, Sullivan J, McDaniel SS. Incidence of Dravet syndrome in a US population. Paediatrics. 2015;136:1310-5.

Rosander C, Hallbook T. Dravet syndrome in Sweden: a population-based study. Dev Med Child Neurol.2015;57:628-33.

Nakayama T, Ogiwara I, Ito K. Deletions of SCN1A 5′ genomic region with promoter activity in Dravet syndrome. Hum Mutat. 2010;31:820-9.

Mulley JC, Nelson P, Guerrero S. A new molecular mechanism for severe myoclonic epilepsy of infancy: Exonic deletions in SCN1A. Neurology. 2006;67:1094-5.

Hiraiwa-Sofue A, Ito Y, Ohta R, Kimura H, Okumura A. Human herpesvirus 6- associated encephalopathy in a child with Dravet syndrome. Neuropediatric. 2013, 44:155-8.

Tang S, Lin JP, Hughes E, Siddiqui A, Lim M, Lascelles K. Encephalopathy and SCN1A mutations. Epilepsia. 2011;52:26-30.

Chipaux M, Villeneuve N, Sabouraud P. Unusual consequences of status epilepticus in Dravet syndrome. Seizure. 2010;19:190-4.

Takayanagi M, Haginoya K, Umehara N. Acute encephalopathy with a truncation mutation in the SCN1A gene: a case report. Epilepsia. 2010;51:1886-8.

Fisher RS, Cross JH, D’Souza C, French JA, Haut SR, Higurashi N, et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017;58:531-42.

Shmuely S, Sisodiya SM, Gunning WB: Mortality in Dravet syndrome: a review. Epilepsy Behav. 2016;64:69-74.

A Genetic Disorder Guide: What is Dravet Syndrome? Accessed: January 17, 2022: https://yourdna.com/dravet-syndrome/.

Dravet C: The core Dravet syndrome phenotype. Epilepsia.2011;52:3-9.

Wirrell EC, Laux L, Donner E, et al.: Optimizing the Diagnosis and Management of Dravet Syndrome: recommendations From a North American Consensus Panel. Pediatr Neurol. 2017; 68:18-34.

Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM. Prognostic, clinical, and demographic features in SCN1A mutation-positive Dravet syndrome. Brain. 2012;135:2329-36.

Paprocka J, Lewandowska A, Zieliński P, Kurczab B, Emich-Widera E, Mazurczak T. Dravet Syndrome-the Polish family’s perspective study. J Clin Med. 2021;10:1903.

Kang J-Q, Macdonald RL. GABRG2 Mutations Associated with a spectrum of eilepsy syndromes from generalized absence epilepsy to Dravet syndrome. JAMA Neurol. 2016;73:1009.

Carvill GL, Weckhuysen S, McMahon JM. GABRA1 and STXBP1: Novel genetic causes of Dravet syndrome. Neurology.2014;82:1245.

Shi X, Yasumoto S, Nakagawa E, Fukasawa T, Uchiya S, Hirose S. Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome. Brain Dev. 2009;31:758-62.

Patino GA, Claes LRF, Lopez-Santiago LF, et al.: A functional null mutation of SCN1B in a patient with Dravet syndrome. J Neurosci. 2009;29:10764.

Depienne C, Bouteiller D, Keren B. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 reseb bles dravet syndrome but mainly affects females. PLoS. 2009;5:1000381.

Striano P, Mancardi MM, Biancheri R. Brain MRI findings in severe myoclonic epilepsy in infancy and genotype phenotype correlations. Epilepsia. 2007;48:1092-6.

Devinsky O, Nabbout R, Miller I. Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial. Epilepsia. 2019;60:294-302.

Lagae L, Sullivan J, Knupp K. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomized, double-blind, placebo-controlled trial. The Lancet. 2019;394:2243-54.

Lotte J, Haberlandt E, Bernd Neubauer M, Staudt GK: Bromide in patients with SCN1A mutations manifesting as Dravet syndrome. Neuropediatric. 2012;43:17-21.

Saito Y, Oguni H, Awaya Y, Hayashi K, Osawa M. Phenytoin induced choreoathetosis in patients with severe myoclonic epilepsy in infancy. Neuropediatrics. 2001;32:231-5.

Horn CS, Ater SB, Hurst DL. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol.1986;2:340-5.

Wheless JW, Fulton SP, Mudigoudar BD. Dravet syndrome: A review of current management. Pediatr Neurol. 2020;07:28-40.

Strzelczyk A, Schubert-Bast S. A practical guide to the treatment of Dravet syndrome with anti-seizure medication. CNS Drugs. 2022;36:217-37.

Downloads

Published

2024-08-27

How to Cite

Patel, P., Bhattacharjee, P., Mishra, K., Trivedi, P., & Parashar, A. (2024). Dravet syndrome an unusual cause of atypical febrile seizure: a case report. International Journal of Contemporary Pediatrics, 11(9), 1312–1316. https://doi.org/10.18203/2349-3291.ijcp20242349

Issue

Section

Case Reports